From: Role of HOXA9 in solid tumors: mechanistic insights and therapeutic potential
miRNAs | Tumor type | Target | Functions | PMID | References |
---|---|---|---|---|---|
miR-1294 | Osteosarcoma | HOXA9 | miR-1294 functions as a tumor suppressor in OS progression by targeting HOXA9 | 30575897 | [78] |
miR-429 | Osteosarcoma | HOXA9 | miR-429 suppressed OS progression by targeting HOXA9 through Wnt/β-catenin pathway | 32782562 | [54] |
miR-873 | Osteosarcoma | HOXA9 | miR-873 suppresses the development of OS by directly targeting HOXA9 and inhibiting the Wnt/β-catenin pathway | 30816476 | [79] |
miR-652 | Osteosarcoma | HOXA9 | miR-652 may negatively regulate HOXA9 expression and inhibit the proliferation, migration, and invasion abilities of osteosarcoma cells through the PI3K/Akt signaling pathway | 35111226 | [58] |
miR-641 | Osteosarcoma | HOXA9 | miR-641 was found to target the 3' untranslated region of homeobox protein Hox-A9 (HOXA9) and suppressed the expression of HOXA9 | 30838699 | [81] |
miR-182 | Osteosarcoma | HOXA9 | miR-182 downregulates Wnt/β-catenin signaling, inhibits cell proliferation, and promotes apoptosis in osteosarcoma cells by suppressing HOXA9 expression | 29254169 | [80] |
miR-139-5p | Osteosarcoma | HOXA9 | miR-139-5p depressed the invasion, proliferation, and EMT of osteosarcoma cells via targeting HOXA9 | 35800618 | [80] |
miR-638 | Glioma | HOXA9 | miR-638 as a tumor suppressor regulates cellular malignancy of gliomas through targeting HOXA9 | 30536324 | [83] |
miR-647 | Glioma | HOXA9 | HOXA9 was validated a direct target of tumor suppressor miR-647 | 31881106 | [84] |
miR-182-5p | Non-small cell lung cancer | HOXA9 | MiR-182-5p may exert oncogenic influence on NSCLC through regulating target genes such as HOXA9 | 31906958 | [85] |
miR-196p | Non-small cell lung cancer | HOXA9 | HOXA9 expression is inversely correlated with miR-196b levels in clinical NSCLC samples as compared to that in corresponding control samples | 26586336 | [41] |
miR-19b-3p | Non-small cell lung cancer | HOXA9 | High expression of miR-19b-3p was found to be capable of predicting poor clinical prognosis in NSCLC patients | 35274735 | [86] |
miR-633 | Colorectal adenocarcinoma | HOXA9 | PCED1B-AS1 could negatively regulate the expression of HOXA9 by sponging miR-633 | 35176937 | [87] |
miR-381-3p | Human anaplastic thyroid carcinoma | HOXA9 | miR-381-3p may function as a tumour suppressor to impede proliferation, migration and invasion and induce apoptosis of DOX-resistant SW1736 and CAL62 cells by inhibiting HOXA9 protein expression | 34719830 | [88] |
miR-638 | Breast cancer | HOXA9 | miR-638 inhibits breast cancer progression through binding to HOXA9 | 34416888 | [55] |
miR-652 | Uveal Melanoma | HOXA9 | miR-652 as an oncogene promoted HIF-1alpha signaling via repression of HOXA9 in uveal melanoma cells | 31740654 | [46] |
miR-133b | Colorectal cancer | HOXA9 | miR-133b targeted the HOXA9/ZEB1 pathway to promote tumor metastasis in CRC cells | 28969042 | [89] |
miR-139-5p | Oral squamous carcinoma | HOXA9 | miR-139-5p could directly inhibit HOXA9, which might be a potential mechanism in inhibiting the proliferation, invasiveness and migration of OSCC cells | 28780773 | [90] |